These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 14566203)

  • 1. Treatment of posttraumatic stress disorder: the impact of paroxetine.
    Davidson JR
    Psychopharmacol Bull; 2003; 37 Suppl 1():76-88. PubMed ID: 14566203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM; Kohn SR; Henderson M; Brown NL
    Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.
    Marshall RD; Schneier FR; Fallon BA; Knight CB; Abbate LA; Goetz D; Campeas R; Liebowitz MR
    J Clin Psychopharmacol; 1998 Feb; 18(1):10-8. PubMed ID: 9472837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Posttraumatic stress disorder (PTSD)].
    Martényi F
    Orv Hetil; 2004 Nov; 145(46):2315-22. PubMed ID: 16106902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three paradigms in the treatment of posttraumatic stress disorder].
    Martényi F
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):11-21. PubMed ID: 16167463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for post-traumatic stress disorder: a comprehensive review.
    Davis LL; English BA; Ambrose SM; Petty F
    Expert Opin Pharmacother; 2001 Oct; 2(10):1583-95. PubMed ID: 11825301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of newer antidepressants for panic disorder.
    Gorman JM
    J Clin Psychiatry; 1997; 58 Suppl 14():54-8; discussion 59. PubMed ID: 9418747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder.
    Vermetten E; Vythilingam M; Southwick SM; Charney DS; Bremner JD
    Biol Psychiatry; 2003 Oct; 54(7):693-702. PubMed ID: 14512209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.
    Davidson JR
    J Clin Psychiatry; 2000; 61 Suppl 5():52-6; discussion 57-9. PubMed ID: 10761679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological therapies for posttraumatic stress disorder: an overview.
    Davidson JR
    J Clin Psychiatry; 1997; 58 Suppl 9():29-32. PubMed ID: 9329449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
    Kroenke K; West SL; Swindle R; Gilsenan A; Eckert GJ; Dolor R; Stang P; Zhou XH; Hays R; Weinberger M
    JAMA; 2001 Dec; 286(23):2947-55. PubMed ID: 11743835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in stress reactivity after long-term treatment with paroxetine in women with posttraumatic stress disorder.
    Vermetten E; Vythilingam M; Schmahl C; DE Kloet C; Southwick SM; Charney DS; Bremner JD
    Ann N Y Acad Sci; 2006 Jul; 1071():184-202. PubMed ID: 16891570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice.
    Shiner B; Westgate CL; Gui J; Maguen S; Young-Xu Y; Schnurr PP; Watts BV
    J Clin Psychiatry; 2018 Sep; 79(5):. PubMed ID: 30257081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine: an update of its use in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine: a review.
    Bourin M; Chue P; Guillon Y
    CNS Drug Rev; 2001; 7(1):25-47. PubMed ID: 11420571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focus on paroxetine.
    Green B
    Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
    J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans.
    Naylor JC; Dolber TR; Strauss JL; Kilts JD; Strauman TJ; Bradford DW; Szabo ST; Youssef NA; Connor KM; Davidson JR; Marx CE
    Psychiatry Res; 2013 Apr; 206(2-3):318-20. PubMed ID: 23276723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.